TomoTherapy and Hitachi Medical Corporation Sign Letter of Intent for Hi·Art® System Distribution in Japan

October 17, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ:TOMO) announced today that it has signed a letter of intent with Hitachi Medical Corporation (HMC) to distribute the Hi·Art® cancer treatment system in Japan.

Twitter
LinkedIn
Facebook
Email
Print

Alliances